pramlintide glp 1 Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management Focus on Glucagon-like Peptide-1 Target:

Learn the safe version, who should avoid it, and how it compares to actual Ozempic

Adults with obesity and autoimmune disease taking GLP-1 medication experience fewer cardiac events and have a lower risk of death, according to new findings.

Learn how GLP-1 medications may affect vision, from blurry sight to rare risks, plus potential eye health benefits and when to see an eye doctor.

The role of GLP-1 RAs was also investigated using the Inverse Probability Treatment Weighting (IPTW) and in the subgroup analyses

Semaglutide and Tirzepatide) have become increasingly popular for the treatment of obesity and overweight

The effects of GLP-1 weight loss can be more pronounced, with: